Whether you have insurance or require affordable self-pay options, we are ready to help
Choosing between these peptides requires understanding not just what the data shows, but what the data means for real-world use
Generally, patients with a BMI of 30 or higher may be prescribed medication
Prime Labs Tirzepatide is supplied exclusively for scientific research and in-vitro study
Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
He was 33, weighed 280 pounds, and had been fighting psoriasis and psoriatic arthritis for a decade
.png)
